Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

NCT: NCT06144554 · RECRUITING

NCT IDNCT06144554
StatusRECRUITING
Start Date2023-09-25
Completion2028-09

Brief Summary

This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.

Frequently Asked Questions

What is Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes?

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes is a clinical trial registered under NCT06144554. Current status: RECRUITING.

What is the status of NCT06144554?

The current status of NCT06144554 (Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes) is: RECRUITING.

When did Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes start?

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes started on 2023-09-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑